Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung Transplantation.

Hernando TrujilloAna HuertaRodrigo AlonsoMaria Luisa SerranoMyriam AguilarEnrique MoralesTeresa Cavero

Published in: Clinical transplantation (2024)

TMA after LT is infrequent but potentially devastating. Our findings suggest that short cycles of eculizumab may be effective for severe TMA after LT.

Keyphrases

extracorporeal membrane oxygenation
early onset
combination therapy
myasthenia gravis